Axon-Beal Limited 08558727 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of sales of dental equipment Digita Accounts Production Advanced 6.30.9574.0 true true 08558727 2023-04-01 2024-03-31 08558727 2024-03-31 08558727 bus:OrdinaryShareClass1 2024-03-31 08558727 core:CurrentFinancialInstruments 2024-03-31 08558727 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08558727 core:FurnitureFittingsToolsEquipment 2024-03-31 08558727 core:MotorVehicles 2024-03-31 08558727 bus:SmallEntities 2023-04-01 2024-03-31 08558727 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 08558727 bus:FullAccounts 2023-04-01 2024-03-31 08558727 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08558727 bus:RegisteredOffice 2023-04-01 2024-03-31 08558727 bus:Director1 2023-04-01 2024-03-31 08558727 bus:Director2 2023-04-01 2024-03-31 08558727 bus:Director3 2023-04-01 2024-03-31 08558727 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08558727 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08558727 core:FurnitureFittings 2023-04-01 2024-03-31 08558727 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 08558727 core:MotorVehicles 2023-04-01 2024-03-31 08558727 core:OfficeEquipment 2023-04-01 2024-03-31 08558727 core:Vehicles 2023-04-01 2024-03-31 08558727 countries:AllCountries 2023-04-01 2024-03-31 08558727 2023-03-31 08558727 core:FurnitureFittingsToolsEquipment 2023-03-31 08558727 core:MotorVehicles 2023-03-31 08558727 2022-04-01 2023-03-31 08558727 2023-03-31 08558727 bus:OrdinaryShareClass1 2023-03-31 08558727 core:CurrentFinancialInstruments 2023-03-31 08558727 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 08558727 core:FurnitureFittingsToolsEquipment 2023-03-31 08558727 core:MotorVehicles 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08558727

Axon-Beal Limited

trading as Clark Dental Sales

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Axon-Beal Limited

trading as Clark Dental Sales

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 8

 

Axon-Beal Limited

trading as Clark Dental Sales

Company Information

Directors

Mrs Jayne Beal

Mr James Henry Beal

Mr Richard William Beal

Registered office

Suite 18
Edwin Foden Business Centre
Moss Lane
Sandbach
Cheshire
CW11 3AE

 

Axon-Beal Limited

trading as Clark Dental Sales

(Registration number: 08558727)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

52,114

52,426

Current assets

 

Stocks

5

175,413

118,721

Debtors

6

946,824

533,930

Cash at bank and in hand

 

1,191,459

1,142,115

 

2,313,696

1,794,766

Prepayments and accrued income

 

5,752

5,360

Creditors: Amounts falling due within one year

(1,192,461)

(839,691)

Net current assets

 

1,126,987

960,435

Total assets less current liabilities

 

1,179,101

1,012,861

Provisions for liabilities

(2,291)

(5,025)

Accruals and deferred income

 

(177,785)

(153,895)

Net assets

 

999,025

853,941

Capital and reserves

 

Called up share capital

7

2

2

Retained earnings

999,023

853,939

Shareholders' funds

 

999,025

853,941

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Axon-Beal Limited

trading as Clark Dental Sales

(Registration number: 08558727)
Abridged Balance Sheet as at 31 March 2024

Approved and authorised by the Board on 10 March 2025 and signed on its behalf by:
 

.........................................
Mrs Jayne Beal
Director

.........................................
Mr Richard William Beal
Director

 
     
 

Axon-Beal Limited

trading as Clark Dental Sales

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales .

The address of its registered office is:
Suite 18
Edwin Foden Business Centre
Moss Lane
Sandbach
Cheshire
CW11 3AE
United Kingdom

These financial statements were authorised for issue by the Board on 10 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Axon-Beal Limited

trading as Clark Dental Sales

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

25% Reducing balance

Office equiptment

25% Reducing balance

Fixtures and fittings

15% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Axon-Beal Limited

trading as Clark Dental Sales

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Axon-Beal Limited

trading as Clark Dental Sales

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2023 - 7).

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2023

10,753

102,290

113,043

Additions

3,421

10,625

14,046

At 31 March 2024

14,174

112,915

127,089

Depreciation

At 1 April 2023

8,331

52,286

60,617

Charge for the year

1,414

12,944

14,358

At 31 March 2024

9,745

65,230

74,975

Carrying amount

At 31 March 2024

4,429

47,685

52,114

At 31 March 2023

2,422

50,004

52,426

5

Stocks

2024
£

2023
£

Other inventories

175,413

118,721

6

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

 

Axon-Beal Limited

trading as Clark Dental Sales

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

7

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary of £1 each

2

2

2

2